Skip to content

NRXP

NRX Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.46
+9.60%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
15.77x
P/S forward
1.02x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
-625.24x
Price / sales
31.32x
Price / cash flow
-5.38x

Enterprise value

Enterprise value
$80.9M
EV / sales
23.82x
EV / EBITDA
-3.70x
EV / EBIT
-4.05x
Market cap
$106.3M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026